Daniel Lee - Tissue Regenix CEO Director
| TRX Stock | 58.50 1.50 2.50% |
CEO
Daniel Lee is CEO Director of Tissue Regenix Group
| Age | 64 |
| Address | Phoenix Court, Garforth, United Kingdom, LS25 2GY |
| Phone | 44 33 0430 3052 |
| Web | https://www.tissueregenix.com |
Daniel Lee Latest Insider Activity
Tracking and analyzing the buying and selling activities of Daniel Lee against Tissue Regenix stock is an integral part of due diligence when investing in Tissue Regenix. Daniel Lee insider activity provides valuable insight into whether Tissue Regenix is net buyers or sellers over its current business cycle. Note, Tissue Regenix insiders must abide by specific rules, including filing SEC forms every time they buy or sell Tissue Regenix'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Daniel Lee few days ago Acquisition by Daniel Lee of 69027 shares of Full House at 4.62 subject to Rule 16b-3 | ||
Daniel Lee over two months ago Disposition of 16918 shares by Daniel Lee of Full House at 1.25 subject to Rule 16b-3 | ||
Daniel Lee over two months ago Disposition of 7285 shares by Daniel Lee of Full House at 1.25 subject to Rule 16b-3 | ||
Daniel Lee over two months ago Disposition of 13002 shares by Daniel Lee of Full House at 1.25 subject to Rule 16b-3 |
Tissue Regenix Management Efficiency
At present, Tissue Regenix's Other Current Assets are projected to increase significantly based on the last few years of reporting. Tissue Regenix's management efficiency ratios could be used to measure how well Tissue Regenix manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| JeanMarc Gilson | Westlake Chemical Corp | 62 | |
| Albert Chao | Westlake Chemical Corp | 74 | |
Management Performance
| Return On Equity | -0.0331 | ||||
| Return On Asset | 0.005 |
Tissue Regenix Group Leadership Team
Elected by the shareholders, the Tissue Regenix's board of directors comprises two types of representatives: Tissue Regenix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tissue. The board's role is to monitor Tissue Regenix's management team and ensure that shareholders' interests are well served. Tissue Regenix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tissue Regenix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pr Ingham, Consultant | ||
| Daniel Lee, CEO Director | ||
| Kirsten Lund, EMEA Secretary | ||
| Christine Rowley, Technical Director | ||
| Tina Trimble, Donor President | ||
| David Cocke, CFO Director |
Tissue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tissue Regenix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0331 | ||||
| Return On Asset | 0.005 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 47.34 M | ||||
| Shares Outstanding | 71.23 M | ||||
| Shares Owned By Insiders | 51.91 % | ||||
| Shares Owned By Institutions | 34.85 % | ||||
| Price To Book | 1.72 X | ||||
| Price To Sales | 1.31 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Tissue Stock
Tissue Regenix financial ratios help investors to determine whether Tissue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tissue with respect to the benefits of owning Tissue Regenix security.